Marpai (NASDAQ:MRAI – Get Free Report) was upgraded by equities researchers at Maxim Group from a “hold” rating to a “buy” rating in a research note issued to investors on Thursday, Benzinga reports. The brokerage currently has a $6.00 price target on the stock. Maxim Group’s target price suggests a potential upside of 130.77% from the company’s current price.
Marpai Trading Up 25.0 %
MRAI stock traded up $0.52 during mid-day trading on Thursday, reaching $2.60. The company’s stock had a trading volume of 544,923 shares, compared to its average volume of 875,598. The company has a market cap of $26.70 million, a price-to-earnings ratio of -0.59 and a beta of 5.25. The business’s 50 day moving average price is $1.63 and its 200 day moving average price is $1.31. Marpai has a 12 month low of $0.33 and a 12 month high of $13.60.
Marpai (NASDAQ:MRAI – Get Free Report) last released its quarterly earnings data on Tuesday, March 26th. The company reported ($0.65) EPS for the quarter. The firm had revenue of $8.71 million for the quarter. Marpai had a negative net margin of 77.38% and a negative return on equity of 789.96%.
Insider Activity at Marpai
Institutional Inflows and Outflows
A hedge fund recently raised its stake in Marpai stock. Vanguard Group Inc. lifted its position in shares of Marpai, Inc. (NASDAQ:MRAI – Free Report) by 63.0% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 363,332 shares of the company’s stock after buying an additional 140,407 shares during the period. Vanguard Group Inc. owned about 1.79% of Marpai worth $654,000 as of its most recent SEC filing. 49.75% of the stock is owned by institutional investors.
About Marpai
Marpai, Inc, a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, health savings account administration, bill review and cost containment services.
Further Reading
- Five stocks we like better than Marpai
- Technology Stocks Explained: Here’s What to Know About Tech
- 3 Value Stocks Too Small For Buffett’s Portfolio
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Foot Locker Builds Up Another Head of Steam; Gains Imminent
- Which Wall Street Analysts are the Most Accurate?
- Disney Stock Catches 3 Upgrades In a Single Week
Receive News & Ratings for Marpai Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marpai and related companies with MarketBeat.com's FREE daily email newsletter.